Search Results - "Hernández Marín, Berta"

Emotional Distress in Cancer Patients During the First Wave of the COVID-19 Pandemic by Toquero, Patricia, Blanco Fernández, Carmen, López Martí, María Pilar, Hernández Marín, Berta, Vera Cea, E Beatriz, Garrido García, Ana, Méndez Carrascosa, Elena, Bañón Torres, Dulce, Donnay Candil, Olga, Ballesteros García, Ana Isabel, Sánchez-Torres, José Miguel, Costas Rojo, Pablo, Mondéjar, Rebeca, Colomer, Ramon, Romero-Laorden, Nuria

“…The COVID-19 pandemic has caused mental health problems worldwide. The psychopathological implications of COVID-19 in cancer patients have rarely been…”
Get full text

Neoadjuvant Treatment in Locally Advanced Thyroid Carcinoma by Navas Moreno, Víctor, Sebastián Valles, Fernando, Lahera Vargas, Marcos, Hernández Marín, Berta, Carrillo López, Elena, Marazuela, Mónica, Muñoz de Nova, José Luis

“…Although the focus in the last decades has been on the overdiagnosis of incidentally detected thyroid carcinomas in early stages, the other extreme of the…”
Get full text

Is Older Age an Independent Prognostic Factor of Survival in Metastatic Colorectal Cancer? by Toquero, Patricia, Mondéjar, Rebeca, Romero-Laorden, Nuria, Méndez, Elena, Castillo, Lucía, Hernández Marín, Berta, Donnay, Olga, Colomer, Ramon

“…Older patients (≤75 years) with advanced colorectal cancer (CRC) may have worse survival than non-older patients. We hypothesized that, rather than age alone,…”
Get more information

PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer by Bocanegra, Ana, Fernandez-Hinojal, Gonzalo, Zuazo-Ibarra, Miren, Arasanz, Hugo, Garcia-Granda, Maria Jesus, Hernandez, Carlos, Ibañez, Maria, Hernandez-Marin, Berta, Martinez-Aguillo, Maite, Lecumberri, Maria Jose, Fernandez de Lascoiti, Angela, Teijeira, Lucia, Morilla, Idoia, Vera, Ruth, Escors, David, Kochan, Grazyna

“…PD-L1 tumor expression is a widely used biomarker for patient stratification in PD-L1/PD-1 blockade anticancer therapies, particularly for lung cancer…”
Get full text

Effectiveness, Toxicity, and Survival Predictors of Regorafenib in Metastatic Colorectal Cancer: A Multicenter Study of Routinely Collected Data by Calvo-García, Alberto, Abánades, María Pérez, Ruíz-García, Silvia, Román, Ana Beatriz Fernández, Fernández, Javier Letellez, García, Beatriz Candel, Terciado, Carlos Hernández, Álvarez, Raquel De Santiago, Solis, Rebeca Mondéjar, Marin, Berta Hernández, Diez, Patricia Toquero, Baladrón, Alberto Morell, Bosch, Ramón Colomer

“…To assess the effectiveness and toxicity of regorafenib in patients with metastatic colorectal cancer (mCRC) in routine clinical practice, as well as…”
Get more information